206 related articles for article (PubMed ID: 29044882)
1. Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells.
Xu Y; Dong X; Qi P; Ye Y; Shen W; Leng L; Wang L; Li X; Luo X; Chen Y; Sun P; Xiang R; Li N
Stem Cells; 2017 Dec; 35(12):2351-2365. PubMed ID: 29044882
[TBL] [Abstract][Full Text] [Related]
2. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
3. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
7. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
8. CCL1 is a major regulatory T cell attracting factor in human breast cancer.
Kuehnemuth B; Piseddu I; Wiedemann GM; Lauseker M; Kuhn C; Hofmann S; Schmoeckel E; Endres S; Mayr D; Jeschke U; Anz D
BMC Cancer; 2018 Dec; 18(1):1278. PubMed ID: 30572845
[TBL] [Abstract][Full Text] [Related]
9. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
10. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1
Wang M; Qin Z; Wan J; Yan Y; Duan X; Yao X; Jiang Z; Li W; Qin Z
Cancer Immunol Immunother; 2022 Nov; 71(11):2717-2730. PubMed ID: 35428909
[TBL] [Abstract][Full Text] [Related]
12. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
13. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment.
Mou W; Xu Y; Ye Y; Chen S; Li X; Gong K; Liu Y; Chen Y; Li X; Tian Y; Xiang R; Li N
Cancer Lett; 2015 Mar; 358(2):115-123. PubMed ID: 25444903
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
[TBL] [Abstract][Full Text] [Related]
16. Antitumor DNA vaccination against the Sox2 transcription factor.
Polakova I; Duskova M; Smahel M
Int J Oncol; 2014 Jul; 45(1):139-46. PubMed ID: 24789529
[TBL] [Abstract][Full Text] [Related]
17. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.
Liu S; Zhang C; Wang B; Zhang H; Qin G; Li C; Cao L; Gao Q; Ping Y; Zhang K; Lian J; Zhao Q; Wang D; Zhang Z; Zhao X; Yang L; Huang L; Yang B; Zhang Y
Cancer Immunol Immunother; 2021 Sep; 70(9):2601-2616. PubMed ID: 33576874
[TBL] [Abstract][Full Text] [Related]
19. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
Gernapudi R; Yao Y; Zhang Y; Wolfson B; Roy S; Duru N; Eades G; Yang P; Zhou Q
Breast Cancer Res Treat; 2015 Apr; 150(3):685-95. PubMed ID: 25783182
[TBL] [Abstract][Full Text] [Related]
20. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]